Clinical trial

Analgesic Effects of Caudal S-ketamine for Supplementation of Ropivacaine Caudal Analgesia in Children With Hypospadias

Name
Caudal S-ketamine
Description
Caudal analgesia with ropivacaine is commonly used in sub-umbilical pediatric surgery. However, increasing the dosage of ropivacaine has not been found to prolong the action significantly while complications will be serious. Ketamine as an additive to caudal administration had been shown to prolong the duration of postoperative analgesia, while the analgesic effectiveness of S-ketamine, the S(+)-enantiomer of ketamine with less possibility to induce psychomotor disturbances, is not clear. In this prospective randomized double-blind clinical trial , the investigators aimed to study the effect of S-ketamine as additive on the duration of caudal analgesia.
Trial arms
Trial start
2023-06-20
Estimated PCD
2025-04-30
Trial end
2025-05-01
Status
Recruiting
Phase
Early phase I
Treatment
S-ketamine & Ropivacaine
The experiment group (Group E) will receive a mixture of ropivacaine 0.2% 0.7 ml/kg and preservative-free S-ketamine 0.5 mg/kg caudally for postoperative analgesia.
Arms:
Group E
Ropivacaine
The experiment group (Group C) will receive ropivacaine 0.2% 0.7 ml/kg plain and equial volume saline caudally for postoperative analgesia.
Arms:
Group C
Size
44
Primary endpoint
duration of caudal analgesia
48 hours after the caudal injection
Eligibility criteria
Inclusion Criteria: * informed parent consent, ASA I or II children, between 3months and 18 years of age,and weighing \<28kg, scheduled for elective hypospadias surgery with general anesthesia will be recruited. Exclusion Criteria: * Patients who have congenital abnormalities of lower spine and meninges. * Patients with hypersensitivity to any local anesthetics * Children with coagulation disorders * Presence of Infections at puncture sites * Preexisting neurological disease * Refusal to consent by parent/guardian
Protocol
{'studyType': 'INTERVENTIONAL', 'phases': ['PHASE4'], 'designInfo': {'allocation': 'RANDOMIZED', 'interventionModel': 'PARALLEL', 'interventionModelDescription': 'Parallel Assignment', 'primaryPurpose': 'TREATMENT', 'maskingInfo': {'masking': 'TRIPLE', 'maskingDescription': 'The Patients allocated to study groups using computer generates random list \\& group assignment is sealed in sequentially numbered opaque envelopes that open after induction of anesthesia.', 'whoMasked': ['PARTICIPANT', 'INVESTIGATOR', 'OUTCOMES_ASSESSOR']}}, 'enrollmentInfo': {'count': 44, 'type': 'ESTIMATED'}}
Updated at
2023-10-30

1 organization

2 products

5 indications

Organization
Tao Zhang
Indication
S-ketamine
Indication
Pediatrics
Indication
caudal block
Indication
Hypospadias